In this issue of Deep Matters we follow up the last 2 months' data stories with a further article showing how we make structures and rich data accessible to help synthesize your target molecules better, faster and more cheaply. Plus, we have announcements with both the University of Cambridge iDMT and Imperial College's CDT and other news from around the Group.


At DeepMatter® we believe making structured and rich data accessible is the way to synthesize your target molecules better, faster and more cheaply. In fact we are committed to open data standards (See last months' newsletter or to find out more information on this click here). One way we make your data accessible with our innovative chemistry platform, DigitalGlassware®, is to work within your workflow, be it helping complete notebooks (electronic or paper) or sharing information securely with your colleagues. To facilitate this we have developed several tools that help:

  • Share data securely and easily

  • Automatically generate DigitalGlassware® Recipes from text

To find out more about these tools and how DigitalGlassware® could work within your workflow to make better chemicals, faster and cheaper click here

For a free demonstration of DigitalGlassware® click the button below:


               LATEST NEWS               

University of Cambridge iDMT Collaboration

We are delighted to announce that we have commenced a project with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies (iDMT), an open innovation research centre co-funded by the University of Cambridge, AstraZeneca, Shionogi, and the European Regional Development Fund.
As part of this collaboration we will provide our DigitalGlassware® platform to iDMT as part of the development of a fully digital workflow in the discovery and development of new molecules, materials, reactions and processes.
Read more here



We are pleased to announce that our CEO, Mark Warne, has been invited to chair the Industrial Advisory Board (IAB) at Imperial College's EPSRC Centre for Doctoral Training in Next Generation Synthesis & Reaction Technology (CDT), for the next two years.

Mark's principal role will be to liaise closely with the CDT's network of industrial partners, including AstraZeneca, Bayer, BASF, GlaxoSmithKline, IBM, The Janssen Pharmaceutical Companies of Johnson & Johnson, Mettler-Toledo, Syngenta, and Pfizer.

To find out more click here

Dave Parry VISTA

Last month our Head of Research, Dave Parry, moderated Jan Jensen's (University of Copenhagen) talk on Quantum Chemistry Assisted Synthesis at the VISTA Symposium on Artificial Intelligence and Data Science Assisted Synthesis.
Click here to see a video of the talk


Do you want to work at a future-focused company redefining an entire sector? We are currently recruiting for:

Click here for more details

Many thanks for reading Deep Matters. For more information on DigitalGlassware® or any of our products please visit our website by clicking on the button below

To subscribe to this newsletter click here.


Copyright © 2021 DeepMatter Group, All rights reserved.

Our mailing address is:
38 Queen St, Glasgow, G1 3DX, UK

Want to unsubscribe:
unsubscribe from this list.